Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood

Clinical Nephrology

Volumn 46, Issue 6, 1996, Pages 394-401

  Pereira, B J G ^a   Sundaram, S ^a   Barrett, T W ^a   Butt, N K ^a   Porat, R ^a   King, A J ^a   Dinarello, C A ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokine inducing bacterial products; Hemodialyzer membranes; Pseudomonas aeruginosa

Indexed keywords

BICARBONATE; CELLULOSE ACETATE; CYTOKINE; ENDOTOXIN; HEMOPHAN; INTERLEUKIN 1ALPHA; POLYMYXIN B; TISSUE CULTURE MEDIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIUM CULTURE; BLOOD; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; FILTRATION; HUMAN; MEMBRANE TRANSPORT; MONONUCLEAR CELL; PLASMA; PROVOCATION TEST; PSEUDOMONAS AERUGINOSA; RADIOIMMUNOASSAY; TEMPERATURE; ULTRAFILTRATION;

BACTERIAL TOXINS; BIOCOMPATIBLE MATERIALS; BLOOD; CELLULOSE; HUMANS; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; MEMBRANES, ARTIFICIAL; PLASMA; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; RENAL DIALYSIS; TIME FACTORS; ULTRAFILTRATION;

EID: 0029750526     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baurmeister U, Vienken J, Daum V 1989 High-flux dialysis membranes: Endotoxin transfer by backfiltration can be a problem. Nephrol Dial Transplant 4 (Suppl 3): 89-93
2. Bingel M, Lonnemann G, Shaldon S, Koch KM, Dinarello CA 1986 Human interleukin-1 production during hemodialysis. Nephron 43: 161-163
3. Chen YHU, Hancock REW, Mishell RI 1980 Mitogenic effects of purified outer membrane proteins from pseudomonas aeruginosa. Infect Imm 28: 178-184
4. Cooperstock MS 1974 Inactivation of endotoxin by polymyxin B. Anti-microb Agents Chemotherap 6: 422-425
5. Dinarello CA 1991 Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652
6. Donahue PR, Ahmad S 1992 Dialyzer permeability alteration by reuse. J Am Soc Nephrol 3: 363
7. Evans RC, Holmes CJ 1991 In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 9: 92-101
8. Graeber CW, Halley SE, Lapkin RA, Graeber CA, Kaplan AA 1993 Protein losses with reused dialyzers. J Am Soc Nephrol 4: 349
9. Gray PW, Flaggs G, Leong SR et al. 1989 Cloning of the cDNA of a human neutrophil bactericidal protein. J Biol Chem 264: 9559-9599
10. Harding GB, Klein E, Pass T, Wright R, Million C 1990 Endotoxin and bacterial contamination of dialysis center water and dialysate; a cross sectional survey. Int J Artif Org 13: 39-42
11. Hoess A, Watson S, Siber G, Liddington R 1993 Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, limulus-anti-LPS factor, at 1.5 A resolution. EMBO J 12: 3351-3356
12. Lonnemann G, Binge M, Floege J, Koch KM, Shaldon S, Dinarello CA 1988a Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 33: 29-35
13. Lonnemann G, Endres S, van der Meer JW, Cannon JG, Dinarello CA 1988b A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. Lymphokine Res 7: 75-84
14. Lonnemann G, Behme TC, Lenzner B, Floege J, Schulze M, Cotton CK, Koch KM, Shaldon S 1992a Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 42, 61-68
15. Lonnemann G, Mahiout A, Schindler R, Colton CK 1992b Pyrogen retention by the polyamide membranes. In: Shaldon S, Koch KM (eds) Contrib Nephrol: Polyamide - the evolution of a synthetic membrane for renal therapy 96: 47-63
16. Lonnemann G, Schindler R, Lufft V, Mahiout A, Shaldon S, Koch KM 1995 The role of plasma coating on the permeation of cytokine-inducing substances through dialyzer membranes. Nephrol Dial Transplant 10: 207-211
17. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW 1990 Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 144: 662-666
18. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW 1992 The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 148: 532-537
19. Mathison JC, Wolfson E, Steinemann S, Tobias PS, Ulevitch RJ 1993 Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J Clin Invest 92: 2053-2059
20. Meszaros K, Aberle S, Dedrick R, Machovich R, Horowitz A, Birr C, Theofan G, Parent JB 1994 Monocyte tissue factor induction by lipopolysaccharide (LPS) dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability increasing protein. Blood 83: 2516-2525
21. Misfeldt ML, Legaard PK, Howell SE, Fomella MH, LeGrand RD 1990 Induction of interleukin-1 from murine peritoneal macrophages by pseudomonas aeruginosa exoloxin A. Infect Imm 58: 977-982
22. Pereira HA, Spitznagel JK, Winton EF, Shafer WM, Martin LE, Guzman GS, Pohl J, Scott KW, Marra MN, Kinkade JJ 1990 The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population. Blood 76: 825-834
23. Pereira BJG, Snodgrass B, King AJ, Hogan P 1995 Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kid Int 47: 603-610
24. Peterson J, Hyver SW, Cajias J 1992 Backfiltration during dialysis: A critical assessment. Semin Dial 5: 13-16
25. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA 1991 Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 78: 1275-1281
26. Ronco R, Brendolan A, Crepaldi C, Milan M, Bragantini L, La Greca G 1994 In vitro study of the modified cellulose triacetate dialyzer series "Surefluex". In: Ronco C, La Greca G (eds) Cellulose Triacetate: Evolution of a Dialysis Membrane. Wichtig Editore, Milan p 21-31
27. Salem M, Mujais SK 1993 Technical and functional considerations in choosing hollow-fiber dialyzers. In: Nissenson AR, Fine RN (eds) Dialysis Therapy. Hanley and Belfus, Inc., Philadelphia, p 65-73
28. Schindler R, Marra MN, Mckelligon BM, Lonnemann G, Schulzeck P, Schulze M, Oppermann M, Shaldon S 1993 Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide binding protein (LBP) during hemodialysis. Clin Nephrol 40: 346-351
29. Schumann RR, Leong SR, Flagg GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ 1990 Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431
30. Tobias PS, Soldau K, Ulevitch FJ 1989 Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264: 10867-10871
31. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA 1989 Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 170: 1231-1241